ALBANY — New Yorkers will soon be able to get an asthma inhaler for free. Gov. Kathy Hochul signed legislation Monday requiring insurance companies to cover the full cost of an asthma inhaler without ...

New Yorkers with asthma may soon be able to breathe a little easier. Gov. Kathy Hochul signed legislation Monday that will make inhalers free for many New Yorkers starting in 2027. Under the new law, ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Chiesi USA's asthma inhaler ...

Inhalers that deliver quick relief to patients with asthma and chronic obstructive pulmonary disease (COPD) may be taking a toll on the planet, producing as much climate-warming pollution as more than ...

Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...

Metered-dose inhaler propellants have contributed a rising amount to greenhouse gases in the U.S. Emissions per inhaler declined slightly over the past decade, but an increase in annual prescription ...

Inhalers are the frontline treatment for asthma and COPD, but they come with a steep environmental cost, according to a new UCLA Health study—the largest to date quantifying inhaler-related emissions ...

The people who are most vulnerable to the hard-to-breathe air that comes with climate change may inadvertently be adding to the problem, new research finds. About 34 million Americans have a chronic ...

Inhalers that combine providing immediate relief with a longer-term preventative effect are already recommended as the standard treatment for mild asthma among people aged 12 and above in the UK, US ...

Almost a dozen malicious extensions with 1.7 million downloads in Google's Chrome Web Store could track users, steal browser activity, and redirect to potentially unsafe web addresses. Most of the add ...

Democratic U.S. Senator Maggie Hassan has reportedly launched an investigation into British pharmaceutical giant GSK's (NYSE:GSK) decision to pull the branded Flovent HFA asthma inhaler from the U.S.

U.S. Senator Maggie Hassan (D-NH) is intensifying her scrutiny of GSK Plc (NYSE:GSK) over the company's decision to pull its widely used asthma inhaler, Flovent HFA, from the market. One year after ...